Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 434.45M P/E - EPS this Y 86.40% Ern Qtrly Grth -
Income -291.86M Forward P/E -7.74 EPS next Y 21.00% 50D Avg Chg -
Sales 2.96M PEG - EPS past 5Y - 200D Avg Chg 32.00%
Dividend N/A Price/Book 7.28 EPS next 5Y - 52W High Chg -50.00%
Recommedations 2.20 Quick Ratio 1.08 Shares Outstanding 26.38M 52W Low Chg 212.00%
Insider Own 24.12% ROA -6.78% Shares Float 17.11M Beta 1.84
Inst Own 31.54% ROE -79.11% Shares Shorted/Prior 2.41M/1.94M Price 19.51
Gross Margin 100.00% Profit Margin - Avg. Volume 76,410 Target Price 19.13
Oper. Margin -2,563.48% Earnings Date Nov 7 Volume 46,738 Change -3.70%
About Cibus, Inc.

Cibus, Inc., a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. Cibus, Inc. is based in San Diego, California.

Cibus, Inc. News
12/17/24 Cibus, Albaugh, RTDC affirm collaboration for weed management solution
12/16/24 Cibus, Albaugh LLC and RTDC Company Limited Affirm Collaboration to Enable Commercialization of Cibus’ First Gene Edited Weed Management Solution for U.S. Rice Growers
11/19/24 Cibus and Biographica Announce Collaboration Using Artificial Intelligence (AI) to Advance Disease Resistance in Canola and Oilseed Rape
11/18/24 Cibus to Participate in the 13th Annual Roth Technology Conference
11/14/24 Cibus Achieves Additional Milestone for Next Generation Gene Edits for Sclerotinia Resistance in Canola
11/10/24 Cibus Inc (CBUS) Q3 2024 Earnings Call Highlights: Navigating Challenges and Seizing ...
11/09/24 Cibus Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
11/07/24 Cibus Reports Third Quarter Financial Results and Provides Year-to-Date Business Update for 2024
11/05/24 Cibus Confirms its Herbicide Tolerance (HT2) Trait Shows Increased Tolerance to a Novel Herbicide for Weed Control in Canola
06:00 AM Cibus to Report Third Quarter 2024 Financial Results on November 7, 2024 After the Market Close and Host Conference Call
10/21/24 Cibus Inc. Announces Realigned Organization to Advance its Commercial Opportunities
10/13/24 individual investors who own 43% along with institutions invested in Cibus, Inc. (NASDAQ:CBUS) saw increase in their holdings value last week
10/11/24 Cibus Technology to be Featured on InnovAction Stage at the Euroseeds2024 Congress
09/23/24 Cibus to Participate in the Food+ Forum during the 79th Session of the United Nations General Assembly
09/18/24 Cibus Announces Pricing of Public Offering of Class A Common Stock
09/17/24 Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock
09/10/24 Cibus Completes First Field Trials in UK for Pod Shatter Reduction in Winter Oilseed Rape
08/12/24 Cibus to Participate in Upcoming August Investor Events
08/08/24 Cibus Reports Second Quarter Financial Results and Provides First Half Business Update
08/06/24 Cibus Achieves Positive Initial Field Trial Results for Stacked Gene Edited Herbicide Tolerant Traits in Rice